The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19

被引：0
|
作者：
Narges Najafi
Alireza Davoudi
Hamideh Izadyar
Abbas Alishahi
Armaghan Mokhtariani
Bahareh Soleimanpourian
Mina Tabarrayi
Mahmood Moosazadeh
Zahra Daftarian
Fatemeh Ahangarkani
机构：
[1] Antimicrobial Resistance Research Center,Gastrointestinal Cancer Research Center
[2] Communicable Diseases Institute,undefined
[3] Mazandaran University of Medical Sciences,undefined
[4] Universal Scientific Education and Research Network (USERN),undefined
[5] Student Research Committee,undefined
[6] Mazandaran University of Medical Sciences,undefined
[7] Non-Communicable Diseases Institute,undefined
[8] Mazandaran University of Medical Sciences,undefined
[9] Northbay Medical Center,undefined
[10] Vacaville Center for Primary Care,undefined
来源：
Irish Journal of Medical Science (1971 -) | 2023年 / 192卷 / 3期
关键词：
Angiotensin receptor blockers (ARBs); Angiotensin-converting enzyme inhibitors (ACEIs); COVID-19; Outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1517 / 1523
页数：6
相关论文
共 50 条
  • [31] ACEI inhibitors and ARBs do not increase severity of COVID-19
    Reactions Weekly, 2020, 1802 (1) : 5 - 5
  • [32] The Prognostic Effect of Serum Albumin Level on Outcomes of Hospitalized COVID-19 Patients
    Abdeen, Yazan
    Kaako, Ahmad
    Amin, Zaid Ahmad
    Muhanna, Ala
    Froessl, Luise Josefine
    Alnabulsi, Mohammad
    Okeh, Amira
    Miller, Richard A.
    CRITICAL CARE RESEARCH AND PRACTICE, 2021, 2021
  • [33] Use of Finasteride and Spironolactone in Hospitalized COVID-19 Patients and Their Effect on Severity Outcomes
    Loyola-Nieto, F.
    Ramirez, C. M.
    Said, M. Ziad-M.
    Comas-Garcia, A.
    Gonzalez-Lopez, J. S.
    Mian, A.
    Vazquez-Suarez, A. A.
    Almaguer, A.
    Gomez, V. A.
    Villarreal-Carrillo, C.
    Valencia, I. Y.
    Hussaini, N.
    Varon, D.
    Surani, S. R.
    Varon, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [34] The effect of chronic DOAC treatment on clinical outcomes of hospitalized patients with COVID-19
    Aslan, Burhan
    Akyuz, Abdurrahman
    Isik, Ferhat
    Cap, Murat
    Inci, Umit
    Kaya, Ilyas
    Karahan, Mehmet Zulkuf
    Aktan, Adem
    Bilge, Onder
    Ozbek, Mehmet
    Altintas, Bernas
    Boyraz, Bedrettin
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (09)
  • [35] The effect of ACE inhibitors on inflammation and clinical end-points in COVID-19 patients
    Gunturk, Arzu
    Kavurmaci, Abidin Yusuf
    Kucukardali, Yasar
    Kartufan, Fatma Ferda
    Ezici, Adnan
    Topkaya, Aynur Eren
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2022, 13 (11): : 1201 - 1204
  • [36] Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19
    Sahai, Aditya
    Bhandari, Rohan
    Godwin, Matthew
    McIntyre, Thomas
    Chung, Mina K.
    Iskandar, Jean-Pierre
    Kamran, Hayaan
    Hariri, Essa
    Aggarwal, Anu
    Burton, Robert
    Kalra, Ankur
    Bartholomew, John R.
    McCrae, Keith R.
    Elbadawi, Ayman
    Bena, James
    Svensson, Lars G.
    Kapadia, Samir
    Cameron, Scott J.
    VASCULAR MEDICINE, 2021, 26 (06) : 626 - 632
  • [37] The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure
    Chatrath, Nikhil
    Kaza, Nandita
    Pabari, Punam A.
    Fox, Kevin
    Mayet, Jamil
    Barton, Carys
    Cole, Graham D.
    Plymen, Carla M.
    ESC HEART FAILURE, 2020, 7 (06): : 4443 - 4447
  • [38] ARBs: tolerated in patients intolerant to ACE inhibitors
    Reactions Weekly, 2012, 1414 (1) : 5 - 5
  • [39] Combination of ACE inhibitors and ARBs in elderly patients
    不详
    EJHP PRACTICE, 2011, 17 (03): : 14 - 14
  • [40] Janus Kinase inhibitors for the treatment of hospitalized patients with COVID-19
    Florescu, Diana F.
    Kalil, Andre C.
    CURRENT OPINION IN CRITICAL CARE, 2021, 27 (05) : 493 - 496
12345